Neutrophil-lymphocyte ratio as a predictor of mortality and functional dependence in patients with ischemic stroke
Keywords:
neutrophil lymphocyte index, hospital mortality, cerebral infarctionAbstract
Introduction: In recent years, the possible relationship between an elevated leukogram and its consequent influence on the increase in mortality and the degree of functional dependence due to cerebral infarction has been addressed. Therefore, the calculation of the neutrophil-lymphocyte ratio could be an indicator for the prognosis of these patients.
Objective: To describe the distribution of patients according to neutrophil-lymphocyte ratio values in the first 24 hours of hospitalization, hospital mortality, and functional dependence due to cerebral infarction.
Method: A descriptive, cross-sectional observational study was conducted from January 2024 to December 2024 at the "Capitán Roberto Rodríguez Fernández" Provincial General Teaching Hospital in Morón. The sample consisted of 142 patients, and the sample consisted of 90 patients using non-probability sampling based on inclusion and exclusion criteria. The neutrophil-lymphocyte ratio was calculated for all patients included in the study. Descriptive statistical methods and percentage calculations were used to express the research results.
Results: 87.5 % of all deceased patients and 57.1 % of patients with a Rankin scale score between 4 and 6 had a neutrophil-lymphocyte ratio calculated upon hospital admission greater than 3.
Conclusions: The risk of death and the Rankin scale score were higher when the neutrophil-lymphocyte index calculated in the first 24 hours of admission was higher.
References
1. Molina Ramírez Y, Díaz Chalala JE, Yera Jaramillo BL, Bolufé Vilaza ME, NúñezMora S. Comportamiento de la enfermedad cerebrovascular aguda en una zona rural [Internet]. Rev inf cient. 2021 [acceso: 26/03/2024]; 100(4): e3484. Disponible en: http://scielo.sld.cu/pdf/ric/v100n4/1028-9933-ric-100-04-e3484.pdf
2. Vanja Douglas C, Aminoff J. Current Medical Diagnosis & Treatment. Sixty third Editions. New York: McGraw-Hill Lange; 2024 [acceso: 26/03/2024]. Disponible en: https://accessmedicine.mhmedical.com/Book.aspx?bookid=3343#279685329
3. Ministerio de Salud Pública. Anuario estadístico de salud [Internet]. 2023 [acceso: 26/03/2024].Disponible en: http://files.sld.cu/dne/files/2018/04/Anuario-Electronico-Español-20. Disponible en: https://temas.sld.cu/estadisticassalud/2024/09/30/anuario-estadistico-de-salud-2023/17ed-2018.pdf
4. Reyes Prieto M, Echeverría F, Chuquel C, Lange J, Escalante J. Teoría inflamatoria del sca: índice leuco glucémico como factor pronóstico [Internet]. Argentina: Instituto de cardiología de Corrientes; 2013 [acceso: 26/03/2024]. Disponible en: http://www.socacorr.org.ar/wp
5. Romero-Hernández María D, Gil-Alfaro Issa, Ovando-Diego Liliana. Características clínicas y calidad de vida de los pacientes tras un evento vascular cerebral [Internet]. Rev Mex med. familiar. 2023 [acceso: 13/06/2025]; 10 (3): 89-98.Disponible en: http://www.scielo.org.mx/scielo.php?script=sci_arttext&pid=S2696
6. Rosas-Cabral Alejandro, Ruiz Esparza-Mota José Antonio, Gutiérrez-Campos Rafael, Torres-Cabral Georgina, Robles-Martínez María del Consuelo, Hernández Muñoz Martha. Índice neutrófilo-linfocito, relación plaquetas-linfocito y distribución de la anchura del eritrocito en pacientes con preeclampsia [Internet]. Ginecol obstet Méx. 2022 ; 90(6): 504-512. DOI: https://doi.org/10.24245.gom.v90i6.7473
7. Asociación Médica Mundial. Declaración de Helsinki de la AMM. Principios éticos para las investigaciones médicas en seres humanos. Ratificada en la 64ª Asamblea General, Fortaleza, Brasil, octubre 2013 [Internet]. Helsinki: 18ª Asamblea Mundial; 1964 [acceso: 13/06/2025]. Disponible en: http://www.anmat.gov.ar/comunicados/HELSINSKI_2013.pdf
8. Morales-Díaz A, Pérez Montes de Oca E, Valladares-Reyes D, Hernández-García OL, Marcheco-Moreira O, Smith-Groba J. Caracterización de pacientes con ictus isquémico. Univ. Méd. Pinareña [Internet]. 2023 [acceso: 13/06/2025];19: e909. Disponible en: https://revgaleno.sld.cu/index.php/ump/article/view/909
9. Sánchez-Landers Manuel. Relación neutrófilo-linfocito como biomarcador de deterioro neurológico en ictus isquémico agudo: ensayo científico argumentativo [Internet]. Acta méd. costarric. 2023 [acceso: 13/06/2025]; 65(4): 217-220. Disponible en: http://www.scielo.sa.cr/scielo.php?script=sci_arttext&pid=S000160022023000400217&lng=en
10. Marta-Enguita J, Rubio-Baines I, Aymerich N, Herrera M, Zandio B, Mayor S, et al. Análisis del valor pronóstico de la analítica urgente en el ictus isquémico [acceso: 13/06/2025]. Neurologia. 2022. DOI: https://doi.org/10.1016/j.nrl.2022.03.004
11. Li W, Hou M, Ding Z, Liu X, Shao Y, Li X. Prognostic value of neutrophil- to-lymphocyte ratio in stroke: A systematic review and meta-analysis [Internet]. Front Neurol. 2021 [acceso: 13/06/2025]; 12:686983. Disponible en: https://www.crd.york.ac.uk/prospero/display_record.php?ID=CRD42020186544
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 Luis Antonio Rodríguez Sánchez

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
The authors retain copyright and all unrestricted publication rights.
Medicoquirúrgicas Research is licensed under the Creative Commons Attribution-Noncommercial 4.0 International License (CC BY-NC 4.0) and follows the SciELO Publishing Schema (SciELO PS) for publishing in XML format.
You are free to:
- Share — copy and redistribute the material in any medium or format.
- Adapt — remix, transform, and build upon the material.
The license cannot revoke these freedoms as long as you follow the license terms.
Under the following terms:
- Attribution — You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do this in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
Non-Commercial — You may not use the material for commercial purposes.
No Additional Restrictions — You may not apply legal terms or technological measures that legally restrict others from making any use permitted by the license.
Notices:
You do not have to comply with the license for elements of the material in the public domain or where their use is permitted by an applicable exception or limitation.
No warranties are given. The license may not give you all the permissions you need for your intended use. For example, other rights such as publicity, privacy, or moral rights may limit how you use the material.
